Fingerprint
Dive into the research topics of 'Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLC
Fan Zhang, Wei Guo, Bolun Zhou, Shuhang Wang, Ning Li, Bin Qiu, Fang Lv, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Shugeng Gao*, Jie He
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
41
Citations
(Scopus)